Wilmington, DE, United States of America

Roche Nimblegen, Inc.


USPTO Granted Patents = 20

% Expired Patents = 75.0


Forward Citations = 400

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Roland D Green (9 out of 17 patents)

silverMedal Thomas J Albert (7 out of 17 patents)

bronzeMedal Todd Richmond (5 out of 6 patents)

4.  Klaus-Peter Stengele (4 out of 8 patents)

5.  Mark McCormick (4 out of 7 patents)

6.  Matthew Rodesch (3 out of 5 patents)

7.  Jason Norton (3 out of 4 patents)

8.  Harold R Garner (3 out of 16 patents)

9.  Gary Barrett (3 out of 3 patents)

10.  Emile Nuwaysir (2 out of 5 patents)

11.  Tom Albert (2 out of 2 patents)

12.  Jigar Patel (1 out of 19 patents)

13.  Steven W Smith (1 out of 10 patents)

14.  Jeffrey Jeddeloh (1 out of 3 patents)

15.  Jeremy Beauchamp (1 out of 2 patents)


20 patents:

Roche Nimblegen, Inc. is a biotechnology company specializing in advanced genomic analysis and molecular diagnostics. Based in Wilmington, Delaware, it focuses on developing innovative solutions for high-throughput sequencing and microarray technologies. The company is dedicated to enhancing research capabilities in genomics, enabling scientists and researchers to gain deeper insights into genetic variations and their implications in health and disease. Roche Nimblegen plays a crucial role in the life sciences sector, contributing to advancements in personalized medicine and diagnostics.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Roche Nimblegen, Inc.
20 Patents

#219 in Wilmington, DE

#270 in Delaware

#16,382 in US

#31,233 in the World

Wilmington, DE (US)
Wilmington, DE, United States of America
Forward Citations = 400

30 inventors:

Please report any incorrect information to [email protected]
Loading…